Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-26FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Zydus Lifesciences Limited.
-
FDA approval · 2014-09-26FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride by Aurobindo Pharma Limited.
-
FDA approval · 2014-09-26FDA Approved: TELMISARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for telmisartan submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2014-09-25FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Losartan Potassium from AiPing Pharmaceutical, Inc. under an ANDA, indicating an additional appr…
-
FDA approval · 2014-09-25FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for a generic Losartan Potassium product from Alembic Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-25FDA Approved: QUINAPRIL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Quinapril from Chartwell RX, LLC, authorizing a generic quinapril product under an ANDA.
-
FDA approval · 2014-09-25FDA Approved: TELMISARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's supplemental application for telmisartan.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Antihypertensive Medications and the Risk of Sepsis
A clinical trial update reporting on a completed study about whether antihypertensive medications affect the risk of sepsis.
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control [Phase 2]
A Phase 2 clinical trial is evaluating radiofrequency ablation to control blood pressure and disease progression in autosomal dominant polyc…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide
This completed pharmacoepidemiological study describes hypertensive patients treated with a fixed-dose combination of telmisartan and hydroc…
-
FDA approval · 2014-09-25FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for carvedilol (generic). This is an approval of a supplemental filing for a …
-
FDA approval · 2014-09-24FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation…
-
FDA label_change · 2014-09-24FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation, updat…
-
FDA approval · 2014-09-24FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA supplemental application for EXFORGE HCT (amlodipine/valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2014-09-24FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Sun Pharmaceutical Ind…
-
FDA approval · 2014-09-24FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Strides Pharma Science Limited)
The FDA granted a supplemental approval for a generic fixed-dose combination of amlodipine and valsartan from Strides Pharma Science Limited…
-
FDA approval · 2014-09-24FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for benazepril hydrochloride from Solco Healthcare U.S., LLC, making this generic ACE inhibitor …
-
FDA approval · 2014-09-23FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochloroth…
-
FDA approval · 2014-09-23FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
The FDA approved Sandoz Inc's supplemental application for a generic benazepril hydrochloride and hydrochlorothiazide combination tablet. Th…
-
FDA label_change · 2014-09-23FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., …
-
FDA approval · 2014-09-23FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar (olmesartan medoxomil) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-09-23FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil–hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-09-22FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol by Aurobindo Pharma Limited. This represents approval of a generic carvedilol pro…
-
FDA approval · 2014-09-22FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited under the DOXAZOSIN ANDA, signaling regulatory …
-
FDA approval · 2014-09-22FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for IRBESARTAN by Aurobindo Pharma Limited.